source
- AHRQ cuts $109 million in health services research grants, ending 78 projects earlyAHRQ announced that dozens of health services research grants will stop early, affecting about $109 million still to be spent. The agency said it is reshaping its discretionary award portfolio to…
- Why moving from Big Pharma to a midsize specialty firm can boost impact and leadershipThomas Kolaras, formerly with large pharmaceutical companies, now works at SERB Pharmaceuticals and reflects on the benefits and constraints of big‑pharma environments. He highlights the rigorous p…